Anna Ceccarelli
Overview
Explore the profile of Anna Ceccarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schietroma F, Bensi M, Calegari M, Pozzo C, Basso M, Valente G, et al.
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39893137
Background: The management of colorectal cancer (CRC) is a complex process. Defining the disease burden, assessing the radiological response and identifying the right time for surgery or other locoregional treatments...
2.
Di Mauro A, Santorsola M, Savarese G, Sirica R, Ianniello M, Cossu A, et al.
J Transl Med
. 2025 Jan;
23(1):28.
PMID: 39780166
No abstract available.
3.
Di Mauro A, Santorsola M, Savarese G, Sirica R, Ianniello M, Cossu A, et al.
J Transl Med
. 2024 Dec;
22(1):1107.
PMID: 39639373
Background: Microsatellite instability (MSI) is a well-established predictive biomarker for immune checkpoint inhibitor (ICI) response in metastatic colon cancer. Both high MSI and tumor mutational burden (TMB) are markers of...
4.
Grisolia P, Tufano R, Iannarone C, De Falco A, Carlino F, Graziano C, et al.
J Transl Med
. 2024 Oct;
22(1):938.
PMID: 39407254
Background: Recent studies have highlighted the importance of the cell-free DNA (cfDNA) methylation profile in detecting breast cancer (BC) and its different subtypes. We investigated whether plasma cfDNA methylation, using...
5.
Bocchetti M, Luce A, Iannarone C, Pasquale L, Falco M, Tammaro C, et al.
J Transl Med
. 2024 Jun;
22(1):582.
PMID: 38902710
Background: Exosomes are nanosized vesicles released from all cells into surrounding biofluids, including cancer cells, and represent a very promising direction in terms of minimally invasive approaches to early disease...
6.
Ottaiano A, Santorsola M, Ianniello M, Ceccarelli A, Casillo M, Sabbatino F, et al.
J Transl Med
. 2024 Apr;
22(1):379.
PMID: 38650006
Background: TAS-102 (Lonsurf) is an oral fluoropyrimidine consisting of a combination of trifluridine (a thymidine analog) and tipiracil (a thymidine phosphorylation inhibitor). The drug is effective in metastatic colorectal cancer...
7.
Schietroma F, Anghelone A, Valente G, Beccia V, Caira G, Spring A, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473349
mutations involving codon 61 are rare in metastatic colorectal cancer (mCRC), accounting for only 1-4%, but they have recently been identified with high frequency in the circulating tumor DNA (ctDNA)...
8.
Roelands J, Kuppen P, Ahmed E, Mall R, Masoodi T, Singh P, et al.
Nat Med
. 2023 May;
29(5):1273-1286.
PMID: 37202560
The lack of multi-omics cancer datasets with extensive follow-up information hinders the identification of accurate biomarkers of clinical outcome. In this cohort study, we performed comprehensive genomic analyses on fresh-frozen...
9.
Pupella S, Bianchi M, Ceccarelli A, Calteri D, Lombardini L, Giornetti A, et al.
Blood Transfus
. 2017 May;
16(3):313-320.
PMID: 28488969
Background: Public cord blood banking is currently managed in Italy by a network of 19 regional cord blood banks coordinated by the National Blood Centre and the National Transplant Centre....
10.
Grazzini G, Ceccarelli A, Calteri D, Catalano L, Calizzani G, Cicchetti A
Blood Transfus
. 2013 Dec;
11 Suppl 4:s138-47.
PMID: 24333307
Background: In Italy, the financial reimbursement for labile blood components exchanged between Regions is regulated by national tariffs defined in 1991 and updated in 1993-2003. Over the last five years,...